The impact of fibrodysplasia ossificans progressiva (FOP) on patients and their family members: results from an international burden of illness survey-Reference-Cited by-同舟云学术

The impact of fibrodysplasia ossificans progressiva (FOP) on patients and their family members: results from an international burden of illness survey

Published:2022-09-21 Issue:8 Volume:22 Page:1199-1213
ISSN:1473-7167
Container-title:Expert Review of Pharmacoeconomics & Outcomes Research
language:en
Short-container-title:Expert Review of Pharmacoeconomics & Outcomes Research

Author:

Al Mukaddam Mona¹,Toder Katherine S.¹,Davis Michelle²,Cali Amanda³⁴⁵,Liljesthröm Moira⁶⁷,Hollywood Suzanne²,Croskery Kim⁸,Grandoulier Anne-Sophie⁹,Böing Elaine A.¹⁰,Whalen John D.⁸,Kaplan Frederick S.¹

Affiliation:

1. Departments of Orthopaedic Surgery and Medicine, The Center for Research in FOP and Related Disorders, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA

2. International FOP Association, Kansas City, MO, USA

3. The Radiant Hope Foundation, Mountain Lakes, NJ, USA

4. The Ian Cali FOP Research Fund, PENN Medicine, The Center for Research in FOP and Related Disorders, Philadelphia, PA, USA

5. Tin Soldiers: Global Patient Identification Program, Johannesburg, South Africa

6. Fundación FOP, Buenos Aires, Argentina

7. Argentine Representative to the International President’s Council of the International FOP Association, Buenos Aires, Argentina

8. Ipsen, Slough, UK

9. Ipsen, Paris, France

10. Ipsen, Cambridge, MA, USA

Funder

Ipsen

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Health Policy,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14737167.2022.2115360

Reference50 articles.

1. Online mendelian inheritance in man. #135100 fibrodysplasia ossificans progressiva; FOP. Updated 2017. [cited 2022 Jun 1]. Available from: https://www.omim.org/entry/135100

2. The histopathology of fibrodysplasia ossificans progressiva. An endochondral process.

3. Classic and atypical fibrodysplasia ossificans progressiva (FOP) phenotypes are caused by mutations in the bone morphogenetic protein (BMP) type I receptor ACVR1

4. Epidemiology of the Global Fibrodysplasia Ossificans Progressiva (FOP) Community

5. Prevalence of fibrodysplasia ossificans progressiva (FOP) in France: an estimate based on a record linkage of two national databases

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Trauma patient heterotopic ossification diagnosis is associated with increased hospital length of stay;Injury;2024-04

2. Coding and noncoding RNA profile of human heterotopic ossifications - Risk factors and biomarkers;Bone;2023-11

3. Empfehlungen zur Versorgung von Patient:innen mit FOP;Die Orthopädie;2023-08-21

4. An Atypical Presentation of Fibrodysplasia Ossificans Progressiva and the Imperative for Multidisciplinary Care: A Case Report;Cureus;2023-08-10